Vincerx Pharma, Inc.

Informe acción NasdaqCM:VINC

Capitalización de mercado: US$11.3m

Vincerx Pharma Crecimiento futuro

Future controles de criterios 0/6

Vincerx Pharma's earnings are forecast to decline at 21.6% per annum while its annual revenue is expected to grow at 72.4% per year. EPS is expected to grow by 4.8% per annum.

Información clave

-21.6%

Tasa de crecimiento de los beneficios

4.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Biotechs27.1%
Tasa de crecimiento de los ingresos72.4%
Rentabilidad financiera futuran/a
Cobertura de analistas

Low

Última actualización08 Oct 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely

Aug 21
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Jul 18
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Mar 30
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Sep 22
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?

Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?

Jun 24
Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?

Vincerx Pharma doses first patient in early-stage VIP152 cancer study

Jun 03

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:VINC - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20261-62-43N/A1
12/31/2025N/A-33-27N/A3
12/31/2024N/A-31-12N/A3
6/30/2024N/A-28-28-28N/A
3/31/2024N/A-38-35-35N/A
12/31/2023N/A-40-40-40N/A
9/30/2023N/A-47-46-46N/A
6/30/2023N/A-54-54-54N/A
3/31/2023N/A-61-58-58N/A
12/31/2022N/A-63-60-60N/A
9/30/2022N/A-58-57-57N/A
6/30/2022N/A-66-53-53N/A
3/31/2022N/A-49-45-45N/A
12/31/2021N/A-39-39-33N/A
9/30/2021N/A-49-29-24N/A
6/30/2021N/A-25-19-14N/A
3/31/2021N/A-23-11-6N/A
12/31/2020N/A-17-2-2N/A
9/30/2020N/A000N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: VINC is forecast to remain unprofitable over the next 3 years.

Beneficios vs. Mercado: VINC is forecast to remain unprofitable over the next 3 years.

Beneficios de alto crecimiento: VINC is forecast to remain unprofitable over the next 3 years.

Ingresos vs. Mercado: VINC is forecast to have no revenue next year.

Ingresos de alto crecimiento: VINC is forecast to have no revenue next year.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Insufficient data to determine if VINC's Return on Equity is forecast to be high in 3 years time


Descubre empresas en crecimiento